Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial
Priyanga Ranasinghe,Priyadarshani Galappaththy,Godwin R Constantine,Ranil Jayawardena,Ranil Jayawardena,Hasitha Dhananjaya Weeratunga,Sirimal Premakumara,Prasad Katulanda +7 more
TL;DR: The result of the present study should provide a step change in the evidence guiding current and future policies regarding the use of cinnamon dietary supplementation in patients with type-2 diabetes mellitus.
read more
Abstract: Previous studies have explored the anti-diabetic effects of Cinnamomum cassia extract in vivo and in vitro. However, there are no studies at present exploring the effects of the indigenous species of Sri Lankan cinnamon (Cinnamomum zeylanicum) in patients with diabetes mellitus. The present study aims to evaluate the potential effects of Cinnamomum zeylanicum extract as a pharmaceutical agent in patients with type-2 diabetes mellitus. The study will be conducted as a randomized, double-blind, placebo-controlled clinical trial for a period of 4 months at the Medical Clinic, University Medical Unit, National Hospital of Sri Lanka. A total of 210 subjects with diabetes, in three equal groups, will be recruited for the study. The patients will be randomized in a 1:1:1 ratio according to the method of block randomization and the subjects will be randomly and equally assigned into two test groups (n = 70 each) and one placebo group (n = 70). The population will be stratified at randomization based on age, gender and disease severity. The treatment drug is a capsule containing Cinnamomum zeylanicum extract as the active ingredient and the placebo capsule will contain lactose monohydrate. Two doses of Cinnamomum zeylanicum extracts (250 mg and 500 mg of the cinnamon extract) will be used. The study drugs will be double blinded to both investigators and participants. The visits and the evaluations will be done as follows: screening (visit 0), 1 month (visit 1), 2 months (visit 2), 3 months (visit 3) and 4 months (visit 4). The following primary outcome measures will be evaluated: glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG) and serum insulin. Secondary outcome measures include: Body Mass Index (BMI) and other anthropometric parameters, blood pressure, total cholesterol, low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL) and triglycerides (TAG). Data will be analyzed using SPSS version 14. We describe the protocol for a clinical trial design evaluating the effects of Cinnamomum zeylanicum (Ceylon cinnamon) in patients with type-2 diabetes mellitus. The result of the present study, positive or negative, should provide a step change in the evidence guiding current and future policies regarding the use of cinnamon dietary supplementation in patients with diabetes. Sri Lanka Clinical Trials Registry (SLCTR), identifier: SLCTR/2017/010 (
http://slctr.lk/trials/714
). Registered on 5 April 2017; study protocol version 3.1 21 March 2017.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression.
Serawit Deyno,Serawit Deyno,Kassahun Eneyew,Sisay Seyfe,Naasson Tuyiringire,Naasson Tuyiringire,Emanuel L. Peter,Emanuel L. Peter,Rekik Ashebir Muluye,Casim Umba Tolo,Patrick Engeu Ogwang +10 more
TL;DR: High heterogeneity observed among included studies warrants further clinical trials after standardization of cinnamon formulation.
76
Reduction of blood glucose by plant extracts and their use in the treatment of diabetes mellitus; discrepancies in effectiveness between animal and human studies
TL;DR: The potential afforded by natural products has not yet been realised in the context of treating diabetes mellitus and a systematic, coordinated, international effort is required to achieve the goal of providing anti-diabetic treatments derived from medicinal plants.
Phytochemistry and beneficial impacts of cinnamon (Cinnamomum zeylanicum) as a dietary supplement in poultry diets
Muhammad Saeed,Asghar Ali Kamboh,Shahid Faraz Syed,Daryoush Babazadeh,Imran Suheryani,Qurban Ali Shah,Muhammad Umar,Ihsanullah Kakar,Muhammad Naveed,M.E. Abd El-Hack,Mahmoud Alagawany,Sun Chao +11 more
TL;DR: Its beneficial properties are explored, its optimal dosage for uses by veterinarians, researchers, and nutritionists, as well as its potential to use as a natural feed additive to replace the synthetic antibiotic growth promoters in poultry feed are explored.
37
Abdominal obesity and metabolic syndrome in South Asians: prevention and management.
TL;DR: In this article, the authors discuss the prevalence, associated risk factors, and evidence-based preventive and curative strategies for metabolic syndrome and abdominal obesity in South Asians and conclude that lifestyle, socio-demography, cultural, and body composition are associated with MetS.
37
Efficacy of herbal medicine (cinnamon/fennel/ginger) for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials.
TL;DR: For primary dysmenorrhea, cinnamon/fennel/ginger effectively reduced pain intensity, and cinnamon shortened the duration of pain.
35
References
Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model
Priyanga Ranasinghe,Sanja Perera,Mangala Gunatilake,Eranga Abeywardene,Nuwan Gunapala,Sirimal Premakumara,Kamal Perera,Dilani Lokuhetty,Prasad Katulanda +8 more
TL;DR: C. zeylanicum lowered blood glucose, reduced food intake, and improved lipid parameters in diabetes-induced rats.
Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka Diabetes, Cardiovascular Study (SLDCS).
Prasad Katulanda,Godwin R Constantine,J. G. Mahesh,Rezvi Sheriff,Rohini De A. Seneviratne,Sumedha Wijeratne,M Wijesuriya,Mark I. McCarthy,Amanda I Adler,David R. Matthews +9 more
TL;DR: The prevalence of diabetes mellitus and pre‐diabetes (impaired fasting glucose and impaired glucose tolerance) in adults in Sri Lanka and projections for the year 2030 and factors associated with diabetes and pre-diabetes are presented.
Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial.
Priyanga Ranasinghe,Ranil Jayawardena,Shehani Pigera,W. S. Wathurapatha,Hasitha Dhananjaya Weeratunga,GA Sirimal Premakumara,Prasad Katulanda,Godwin R Constantine,Priyadarshani Galappaththy +8 more
TL;DR: The results demonstrate no significant side effects and toxicity of CZ, including hepatotoxicity and anti-coagulation properties, and CZ demonstrated beneficial anti-hyperlipidaemic and blood pressure lowering effects among healthy adults.
Spirit 2013 statement: Defining standard protocol items for clinical trials
An-Wen Chan,Jennifer Tetzlaff,Douglas G. Altman test,Andreas Laupacis,Peter C Gøtzsche,Karmela Krleža-Jerić,Asbjørn Hróbjartsson,Howard Mann,Kay Dickersin,Jesse A. Berlin,Caroline J Doré,Wendy R. Parulekar,William S.M. Summerskill,Trish Groves,Kenneth F. Schulz,Harold C. Sox,Frank W. Rockhold,Drummond Rennie,David Moher +18 more
TL;DR: The systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 is described, a guideline for the minimum content of a clinical trial protocol.
Insulin resistance and pancreatic β cell failure
TL;DR: It is now well accepted that diabetes mellitus is one of the main threats to human health in the twenty-first century and the number of people with diabetes worldwide is projected to increase to 221 million in 2010 and to 366 million in 2030.